Exact Mass: 416.0163
Exact Mass Matches: 416.0163
Found 86 metabolites which its exact mass value is equals to given mass value 416.0163
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-[(4-{[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-2-methylphenyl)methyl]-1,3-thiazolidine-2,4-dione
1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)-
Perfluoro-2-butyltetrahydrofuran
Flucofuron
CONFIDENCE Identification confirmed with Reference Standard (Level 1); Source 414_9616_msms.txt
mollicellin M
A member of the class of depsidones that is 3,4-dihydro-2H,7H-chromeno[7,6-b][1,4]benzodioxepine substituted by a chloro group at position 9, a hydroxy group at position 10, methyl groups at positions 2, 2, 5 and 8, a formyl group at position 11 and oxo groups at positions 4 and 7. Isolated from Chaetomium brasiliense it exhibits antimalarial and cytotoxic activities.
(2S)-N-[(E)-2-(2,4-dibromo-5-methoxyphenyl)ethenyl]-1-methyl-2-pyrrolidinecarboxamide|amathamide A
clionastatin B
An androstanoid that is androsta-3,5,8,16-tetraene substituted by chloro groups at positions 1, 2, 16 and 19 and oxo groups at positions 7 and 15 (the 1beta,2alpha stereoisomer). It is isolated from burrowing sponge Cliona nigricans and exhibits cytotoxic efficacy.
CAY10597
3,5-dichloro-2-(2,4-dihydroxy-6-methoxycarbonylphenoxy)-6-methoxy-4-methylbenzoic acid
3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid
Geodin Hydrate
EUK-134
N-PROPYL-3-METHYLPYRIDINIUM BIS(TRIFLUOROMETHYLSULFONYL)IMIDE
disodium 2-[(1-hydroxy-4-sulphonato-2-naphthyl)azo]benzoate
sodium 5-chloro-3-[(1,5-dihydroxy-2-naphthyl)azo]-2-hydroxybenzenesulphonate
N-(6-Iodo-2-(trimethylsilyl)furo[3,2-b]pyridin-7-yl)pivalamide
1H-Pyrrolo[2,3-b]pyridine, 3-bromo-5-(1-Methyl-1H-pyrazol-4-yl)-1-(phenylsulfonyl)-
6-[[4-(2,5-Dihydro-2,5-Dioxo-1H-Pyrrol-1-Yl)Phenyl]Amino]-2-Naphthalenesulfonicacid Sodium Salt(1:1)
meso-ethylenebis(1-indenyl)zirconium(iv) dichloride
1-Butylpyridinium bis[(trifluoromethyl)sulfonyl]azanide
2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile
2-methyl-2-[4-[(3,4,5-trichlorophenyl)carbamoylamino]phenoxy]propanoic acid
3-[5-(3-nitrobenzoyl)-1,3-dioxoisoindol-2-yl]benzoic acid
Ethylenediaminetetraacetic acid tetrasodium salt dihydrate
rac-Ethylenebis(2-methyl-1-indenyl)zirconium dichloride
Benzenesulfonothioicacid, 4-methyl-, S1,S1-1,3-propanediyl ester
Crolibulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)-
D004791 - Enzyme Inhibitors
2-[5-[(3,4-Dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
2-[[3-(4-methylphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]-N-(2-thiazolyl)acetamide
2-[5-[(2,4-Dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
3,5-Dichloro-2-(2,4-dihydroxy-6-methoxycarbonylphenoxy)-6-methoxy-4-methylbenzoic acid
disodium 2-hydroxy-5-[(E)-(6-sulfonato-2-naphthyl)diazenyl]benzoate
(1S,2S,10S,13S,14R)-1,2,16-trichloro-10-(chloromethyl)-13-methyl-2,11,12,14-tetrahydro-1H-cyclopenta[a]phenanthrene-7,15-dione
3-[(2Z)-2-(3-ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)-1,3-benzothiazol-3-yl]propane-1-sulfonic acid
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-(4-fluorophenyl)sulfonylprop-2-enenitrile
N-[5-[2-(4-chloroanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-furancarboxamide
4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid
2-[(E)-3-oxo-3-phenylprop-1-enyl]sulfanyl-6-thiophen-2-yl-4-(trifluoromethyl)pyridine-3-carbonitrile
[2,6-Dihydroxy-4-(3,5,6,7-tetrahydroxy-4-oxo-2,3-dihydrochromen-2-yl)phenyl] hydrogen sulate
[5,6,7-Trihydroxy-4-oxo-2-(2,3,4-trihydroxyphenyl)-2,3-dihydrochromen-3-yl] hydrogen sulate
5-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3-hydroxy-4-sulooxycyclohexene-1-carboxylic acid
2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine
BAY-1797
BAY-1797 is a potent, orally active, and selective P2X4 antagonist, with an IC50 of 211 nM against human P2X4. BAY-1797 displays no or very weak activity on the other P2X ion channels. BAY-1797 shows anti-nociceptive and anti-inflammatory effects[1].